KT-1 PAIRED WITH MULTIVALENT POLYMER-ANTI-PD-L1 PEPTIDE HYBRID: A SYNERGISTIC CHEMOIMMUNOTHERAPY FOR TREATMENT OF TRIPLE-NEGATIVE AND METASTATIC BREAST CANCER
$1,497,526FY2020Defense Health AgencyDOD
University Of Utah, Salt Lake City UT
University Of Utah, Salt Lake City UT